144
0001551139
XXXXXXXX
LIVE
0001359931
Protara Therapeutics, Inc.
001-36694
345 Park Avenue South
Third Floor
New York
NY
10010
646-844-0337
667, L.P.
Former Affiliate
Common Stock
Jefferies LLC
520 Madison Avenue
New York
NY
10022
24802
132691.00
55060500
04/23/2026
NASDAQ
Common Stock
09/22/2020
See Remark 2
Underwriter
N
24802
09/24/2020
See Remark 2
N
667, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
02/24/2026
26755
161584.00
667, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
02/25/2026
78716
457046.00
667, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
03/04/2026
35173
220151.00
667, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
03/06/2026
38277
223920.00
(1) 667, L.P. is affiliated with Baker Brothers Life Sciences, L.P. Baker Bros. Advisors LP serves as the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. Baker Brothers Life Sciences, L.P. is filing separately for the sale of 300,176 shares of common stock ("Common Stock") of Protara Therapeutics, Inc. (the "Issuer"), which along with the reported sales in this form by 667, L.P. totals 324,978 shares of Common Stock. (2) Common Stock converted from Series 1 Preferred.
04/23/2026
By: BAKER BROS. ADVISORS LP, mgmt company and IA to 667, L.P., /s/ Scott L. Lessing, President